Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

August 31, 2005

Conditions

HIV Infections

Interventions

DRUG

dapivirine (TMC120) vaginal ring

Trial Locations (1)

Drug Research Unit Gent, Ghent

All Listed Sponsors

collaborator

Tibotec Pharmaceutical Limited

INDUSTRY

lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00332995 - Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium | Biotech Hunter | Biotech Hunter